Gut Peptide GLP-1 and Its Analogue, Exendin-4, Decrease Alcohol Intake and Reward
High doses (1,000+ mg/day) are often needed for minimal effects
Pop, et al
In plain language, the medications may change how alcohol is experienced or perceived
Blood Pressure Fluctuations: Potential to cause dangerous changes in blood pressure
Monday, 09 February 2026 08:00 AM Umbrella Labs Retatrutide Peptide Research Use Only Program Supports High Rigor Multi Receptor Endocrine Signaling, Metabolic Pathway Mapping, And Reproducible Bench Workflows Monday, 09 February 2026 08:00 AM Company Update TUCSON, AZ / ACCESS Newswire / February 9, 2026 / Umbrella Labs today announced an expanded research focused program for retatrutide peptide to support laboratories running multi receptor signaling studies, pathway mapping experiments, and reproducibility forward assay development under controlled bench conditions